52
Participants
Start Date
January 1, 2019
Primary Completion Date
September 30, 2022
Study Completion Date
September 30, 2022
Fluoxetine Hydrochloride
Half of the participants will take fluoxetine for a period of 15-17 weeks (depending on ramp-up period).
Placebo
Half of the participants will take the a placebo for a period of 15-17 weeks (depending on ramp-up period).
Exercise Program
All participants will take part in a 12-week exercise program. The program will run 3 times/week, 1 hour/class.
University of Calgary, Calgary
University of British Columbia & GF Strong Centre, Vancouver
Riverview Health Centre, Winnipeg
Memorial University of Newfoundland, St. John's
Dalhousie University, Halifax
Parkwood Institute, London
Sunnybrook Health Sciences Centre, Toronto
Toronto Rehabilitation Institute - University Health Network, Toronto
Collaborators (1)
University of British Columbia
OTHER
Sunnybrook Health Sciences Centre
OTHER
University of Calgary
OTHER
Dalhousie University
OTHER
Parkwood Hospital, London, Ontario
OTHER
Riverview Health Centre Foundation
OTHER
Memorial University of Newfoundland
OTHER
Applied Health Research Centre
OTHER
Brain Canada
OTHER
Heart and Stroke Foundation Canadian Partnership for Stroke Recovery
UNKNOWN
University Health Network, Toronto
OTHER